Finally, in the independent RNA-seq validation cohort of 98 patients with DLBCL, the prognostic relevance of MAPK10 and CCL18 expression was evaluated using Kaplan–Meier survival analysis (Figure 5). The gene discussed is MAPK10; the disease is diffuse large B-cell lymphoma.